Reneo Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021
Market Capitalization	50	53	57	209
Market Cap Growth	-62.44%	-6.75%	-72.63%	-
Enterprise Value	-31	-49	-43	61
PE Ratio	-	-0.69	-1.10	-5.25
PB Ratio	0.62	0.60	0.57	1.42
P/FCF Ratio	-0.73	-0.83	-1.20	-5.47
P/OCF Ratio	-0.73	-0.84	-1.21	-5.50
EV/EBITDA Ratio	0.38	0.63	0.83	-1.54
EV/EBIT Ratio	0.37	0.63	0.82	-1.54
EV/FCF Ratio	0.35	0.76	0.89	-1.60
Debt / Equity Ratio	0.01	0.01	0.01	-
Debt / EBITDA Ratio	-0.01	-0.01	-0.03	-
Debt / FCF Ratio	-0.01	-0.02	-0.03	-
Quick Ratio	29.44	5.66	14.20	23.81
Current Ratio	29.83	5.87	14.93	24.79
Return on Equity (ROE)	-67.80%	-73.20%	-44.10%	-37.70%
Return on Assets (ROA)	-60.10%	-63.90%	-40.90%	-27.30%
Return on Capital (ROIC)	-93.12%	-92.71%	-53.09%	-27.05%
Earnings Yield	-140.11%	-145.20%	-90.90%	-19.04%
FCF Yield	-150.00%	-119.90%	-83.47%	-18.28%
Buyback Yield / Dilution	-33.49%	-25.23%	-35.01%	-794.56%
Total Shareholder Return	-33.49%	-25.23%	-35.01%	-794.56%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).